Cabazitaxel

Dr Sarah Cant, Head of Policy and Campaigns at The Prostate Cancer Charity, spoke to the Daily Mail and the Daily Telegraph, about cabazitaxel,  a new drug which could  give men with advanced prostate cancer two extra months of life.

Read more